Form 4: Cyanotech Corp: Executive Cysewski Reports Changes in Beneficial Ownership

Gerald R Cysewski, Chief Scientific Officer of Cyanotech Corp, reports changes in beneficial ownership of company stock due to vesting of restricted stock units and associated tax withholding.

Summary

• On April 7, 2025, Gerald R Cysewski, Chief Scientific Officer of Cyanotech Corp, reported changes in his beneficial ownership of the company's common stock.
• These changes are due to the vesting of 33 restricted stock units, which converted into common stock.
• The company withheld 13 shares to cover payroll tax liabilities associated with the vesting.
• Following these transactions, Cysewski directly owns 145,712 shares of common stock and indirectly owns 250 shares held by his spouse.
• He also holds 1,611 restricted stock units that will vest in the future.

Sentiment

Score: 5

Explanation: The document is a neutral regulatory filing detailing stock transactions. It doesn't inherently convey positive or negative sentiment.

Future Outlook

The reporting person's remaining restricted stock units will vest on July 29, 2025 and April 6, 2026, subject to continued service with the company.

Industry Context

This filing is a routine disclosure related to executive compensation and stock ownership, common in publicly traded companies. It provides transparency into the holdings and transactions of company insiders.

Stakeholder Impact

• The transaction has a minor impact on shareholders as it reflects a change in insider ownership, but the number of shares involved is relatively small.

Key Dates

Keywords

beneficial ownership, Form 4, Cyanotech, stock vesting, restricted stock units, insider trading, securities, Cysewski